CD83 and glioblastoma: We then empirically assessed 5 additional variations on culture techniques to generate mature DCs from GBM patient and/or healthy volunteer monocytes before achieving success with a technique (M6) that generated mature CD83+ DCs at frequencies (85.4% ± 7.2%) that were no longer significantly different from mature CD83+ DC frequency from healthy volunteer monocytes using optimized techniques.